Module: molecular
Module Contents
- braf_kras
- 1.CENTER_NO (*PK)
- 2.SOMATIC_CID (*PK)
- 3.PERSON_ID
- 4.TUMOR_NO
- 5.POLYP_NO
- 6.GENE
- 7.VARIANT_ORIGIN
- 8.SOURCE_NUC_ACID
- 9.NUC_ACID_CID
- 10.DETECTION_METHOD
- 11.GENOMIC_REGION_TESTED
- 12.TEST_RESULT
- 13.VARIANT_NAME_RESULT
- 14.EXON_NO
- 15.NUC_POS_START
- 16.NUC_POS_END
- 17.NUCLEOTIDE_FROM
- 18.NUCLEOTIDE_TO
- 19.TYPE_VARIANT
- 20.CODON
- 21.AA_FROM
- 22.AA_TO
- 23.CONSEQUENCE
- 24.LAB_ID
- 25.LAB_OTHER_TEXT
- 26.DATE_TEST
| 1 | CENTER_NO (*PK) | number(2,0) | Required:TRUE | ||||||||||||||||
| Center identification number. *CENTER_NO & SOMATIC_CID are the primary key for the table. | |||||||||||||||||||
| |||||||||||||||||||
| 2 | SOMATIC_CID (*PK) | String (40) | Required:TRUE |
| Centre identifier for the test. *CENTER_NO & SOMATIC_CID are the primary key for the table. | |||
| 3 | PERSON_ID | string (12) | Required:TRUE |
| Number that uniquely identifies an individual. | |||
| 4 | TUMOR_NO | number (2,0) | Required:TRUE | ||||||
| Number labelling the tumor of the individual. Numbers are not necessarily sequential. | |||||||||
| |||||||||
| 5 | POLYP_NO | number (2,0) | Required:TRUE | ||||||
| Sequential number over range of 1 to 99 to distinguish a polyp removed on a particular date. | |||||||||
| |||||||||
| 6 | GENE | number (1,0) | Required:TRUE | ||||||
| Gene on which testing has been performed. | |||||||||
| |||||||||
| 7 | VARIANT_ORIGIN | number (1,0) | Required:TRUE | ||||||||
| Describes if the variant was tested as an acquired or a germline variant. | |||||||||||
| |||||||||||
| 8 | SOURCE_NUC_ACID | number (1,0) | Required:TRUE | ||||||||||||||
| Specifies source of tissue used for testing | |||||||||||||||||
| |||||||||||||||||
| 9 | NUC_ACID_CID | string (15) | Required:TRUE | ||||
| Identifier used internally by centers for a single extraction on which the test was carried out | |||||||
| |||||||
| 10 | DETECTION_METHOD | number (2,0) | Required:TRUE | ||||||||||||
| Somatic DNA testing method. (Mass Spec = Sequenom MassARRAY system, MALDI-TOF) | |||||||||||||||
| |||||||||||||||
| 11 | GENOMIC_REGION_TESTED | string (30) | Required:TRUE |
| Indicates what part(s) of the gene or specific mutation or other genomic region(s) was TESTED | |||
| 12 | TEST_RESULT | number (1,0) | Required:TRUE | ||||||||||
| Result of the test carried out at the tumor level. This is NOT at person level. | |||||||||||||
| |||||||||||||
| 13 | VARIANT_NAME_RESULT | string (30) | Required:FALSE |
| Proper variant name using Human Genomic Variant Society (HGVS) nomenclature. | |||
| 14 | EXON_NO | number (2,0) | Required:false | ||||||
| Number of exon containing variant. In the case the variant spans more than one exon, then this field should indicate the first exon affected by the variant. | |||||||||
| |||||||||
| 15 | NUC_POS_START | string (20) | Required:false |
| For exonic mutations, the numeric value of the nucleotide first affected by the mutation relative to the reference sequence. | |||
| 16 | NUC_POS_END | string (20) | Required:false |
| For exonic mutations, the numeric value of the nucleotide last affected by the mutation relative to the reference sequence. | |||
| 17 | NUCLEOTIDE_FROM | string (1) | Required:false | ||||||||||
| Expected nucleotide with respect to the reference sequence. | |||||||||||||
| |||||||||||||
| 18 | NUCLEOTIDE_TO | string (1) | Required:FALSE | ||||||||||
| Observed (mutated) nucleotide. | |||||||||||||
| |||||||||||||
| 19 | TYPE_VARIANT | number (1,0) | Required:false | ||||||
| Type of genetic change | |||||||||
| |||||||||
| 20 | CODON | number (4,0) | Required:false |
| Numeric location of first mutated amino acid of reference sequence. A numeric value of 1 to the total number of codons on the reference sequence | |||
| 21 | AA_FROM | string (1) | Required:FALSE | ||||||||||||||||||||||||||||||||||||||||||||
| Wild type amino acid value of first affected amino acid on reference sequence | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| 22 | AA_TO | string (1) | Required:FALSE | ||||||||||||||||||||||||||||||||||||||||||||
| Expressed amino acid value of last affected amino acid on reference sequence | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| 23 | CONSEQUENCE | number (1,0) | Required:FALSE | ||||||||
| Category of mutation- defining outcome of the variant | |||||||||||
| |||||||||||
| 24 | LAB_ID | number (3,0) | Required:TRUE | ||||||||||||||||||||||
| Lab or individual who performed the testing. | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| 25 | LAB_OTHER_TEXT | string (30) | Required:false |
| Name of other/private lab | |||
| 26 | DATE_TEST | string (8) | Required:TRUE | ||||||||||
| Date on which test was performed. Format: YYYYMMDD | |||||||||||||
| |||||||||||||